0

Xstrahl In Action: SARRP used in characterization of plastic scintillating detector

In their paper “Characterization of a plastic scintillating detector for the Small Animal Radiation Research Platform (SARRP)” Johnstone CD, Therriault-Proulx F, Beaulieu L & Bazalova-Carter [...]

0

Xstrahl In Action: Xstrahl 200 Used for Research into Clinical Response Following Superficial Radiation Therapy of SCCs

Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer and arises from abnormal growth in the squamous cells of the skin’s outermost layer due to cumulative [...]

0

Xstrahl In Action: Xstrahl 200 Used for Tissue Conservation and Long-Term Control of Melanoma

In their paper “Xstrahl therapy results in tissue conservation and long-term control of melanoma in situ of the lower eyelid” Gerald B Fogarty, Amy Ziebell, Stephanie Nicholls, Susith Kulasekara, [...]

0

Xstrahl In Action: SARRP used in mild hyperthermia as a localized radiosensitizer study

Non-ablative or mild hyperthermia (HT) has been shown in preclinical and clinical studies as a localized radiosensitizer that enhances the tumoricidal effects of radiation. Most preclinical in [...]

0

Xstrahl holds SARRP User Meeting in conjunction with ICRR

Xstrahl would like to say a big thank you to all the participants of the SARRP User Meeting hosted by the Xstrahl Life Sciences team on August 25th, 2019, the first day of the ICRR 2019 [...]

0

Xstrahl In Action: SARRP Used for Research into PET Inclusion for Treatment of Glioblastomas

Glioblastoma (GB) is the most common primary malignant brain tumor in adults. The standard of care consists of maximal possible surgical resection with concomitant radiation therapy (RT) and [...]